Basics Roivant Sciences Ltd. Common Shares IPO Date: January 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $7.59B Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 2.54% Avg Daily Range (30 D): $0.16 | 1.45% Avg Daily Range (90 D): $0.17 | 1.59% Institutional Daily Volume Avg Daily Volume: 2.61M Avg Daily Volume (30 D): 4.79M Avg Daily Volume (90 D): 5.07M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 162 Avg Trade Size (Sh.) (90 D): 154 Institutional Trades Total Inst.Trades: 2,513 Avg Inst. Trade: $3.39M Avg Inst. Trade (30 D): $4.51M Avg Inst. Trade (90 D): $4.14M Avg Inst. Trade Volume: .32M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.97M Avg Closing Trade (30 D): $8.21M Avg Closing Trade (90 D): $8.44M Avg Closing Volume: 749.85K     News Feb 20, 2025 @ 8:22 AM Will Moderna Stock Drop to $25? 1 Wall Street Anal... Source: Eric Volkman Oct 28, 2024 @ 1:25 PM Organon Completes Acquisition of Dermavant, includ... Source: Globe Newswire Sep 18, 2024 @ 7:20 PM Roivant Sciences Offloads Psoriasis Medicine Maker... Source: Benzinga Editor Sep 18, 2024 @ 11:30 AM Organon to Acquire Dermavant including its Innovat... Source: Globe Newswire Sep 10, 2024 @ 6:21 PM Roivant Sciences Unveils New 'Vant' Subsidiary For... Source: Vandana Singh Financials   TTM Q4 2025 FY 2025 Basic EPS $-.24 $-.29 $-.24 Diluted EPS $-.24 $-.29 $-.24 Revenue $ 29.05M $ 7.57M $ 29.05M Gross Profit $ $ $ Net Income / Loss $ -356.73M $ -252.38M $ -356.73M Operating Income / Loss $ -1003.29M $ -284.97M $ -1003.29M Cost of Revenue $ $ $ Net Cash Flow $ -3825.54M $ 724.48M $ -3825.54M PE Ratio